Understanding N-Acylethanolamines (NAEs) and Their Role in Our Endocannabinoid System, The Master Regulator

The endocannabinoid system (ECS) has been referred to as ‘The Master Regulator’ by our CEO for the past eight years by our CEO, Mike Robinson. “It’s a term I use because it’s easy to understand, even in healthcare. Once I say the E word, people think only of the plant that sounds like the word, and not about how our diet and lifestyle influence the ECS, which helps balance nearly every major physiological system,” according to Robinson, which is backed by quite a bit of science. When most people hear about endocannabinoids, they think of the “classic” endocannabinoids – anandamide (AEA) and 2-arachidonoylglycerol (2-AG). But the ECS network is broader than those two messengers. It includes a fascinating family of fatty acid-derived molecules known as N-acylethanolamines (NAEs), which many researchers consider to be minor endocannabinoids.

These bioactive lipids are structurally similar to endocannabinoids, but they work through distinct pathways. Some do not bind to CB1 or CB2 receptors at all, yet they still help shape inflammation, metabolism, pain, mood, and even cell survival. NAEs bridge nutrition, lifestyle, and ECS health – reminding us that what we eat and how we live directly tunes our internal balance.

---

What Are N-Acylethanolamines?

NAEs are naturally occurring molecules derived from fatty acids. They form in cell membranes and circulate in tissues whenever balance needs restoring. While anandamide is technically an NAE, this family also includes several non-classical members such as:

• Palmitoylethanolamide (PEA)
• Oleoylethanolamide (OEA)
• Stearoylethanolamide (SEA)
• Linoleoylethanolamide (LEA)

Unlike endocannabinoids, which target CB1 or CB2 receptors directly, NAEs often act through other receptor systems, which we refer to as “endocannabinoid-like” signaling. This does not make them less critical. In fact, it explains the influence of the ECS across the entire body.

---

How NAEs Interact With Receptor Systems

The ECS is not a closed circuit. It is interconnected with other receptor families, enzymes, and signaling molecules. NAEs highlight this complexity.

• PPARs (Peroxisome Proliferator-Activated Receptors):
  PPAR-alpha is a nuclear receptor that regulates lipid metabolism, inflammation, and energy balance. Both PEA and OEA strongly activate it.
• TRPV1 (Transient Receptor Potential Vanilloid 1):
  Known as the capsaicin receptor, TRPV1 plays a role in pain, temperature sensation, and neurogenic inflammation. Anandamide and some NAEs can sensitize or desensitize this channel.
• GPR55 and GPR119:
  These orphan G-protein receptors are still being mapped, but they appear to regulate glucose handling, appetite, and neuroimmune signaling. NAEs can engage with these, expanding their physiological reach.

This means NAEs act like cross-talkers. Instead of only “turning on” CB1 or CB2, they redirect activity into other circuits that maintain balance.

---

Spotlight on Palmitoylethanolamide (PEA)

PEA is one of the most studied NAEs. First identified in the 1950s in egg yolks and peanuts, it was later shown to reduce inflammation and allergic reactions. Today it is recognized for its neuroprotective, anti-inflammatory, and analgesic properties.

What makes PEA unique is that it does not bind CB1 or CB2. Instead, it:

• Activates PPAR-alpha, reducing pro-inflammatory cytokines
• Enhances anandamide signaling, a phenomenon called the “entourage effect”
• Interacts with mast cells and microglia, calming immune overactivation in the brain and peripheral tissues

A pivotal study titled “Palmitoylethanolamide, a Naturally Occurring Lipid, Is an Endogenous Ligand for the Nuclear Receptor PPAR-Alpha” (2002) showed how PEA activates PPAR-alpha to reduce inflammation. This helped solidify its role as a natural modulator of pain and immunity.

PEA has since been trialed for neuropathic pain, fibromyalgia, multiple sclerosis, and even neurodegenerative disorders. It is well tolerated, available as a supplement in some regions, and has decades of safety data.

---

Oleoylethanolamide (OEA) and Appetite Regulation

OEA is another standout NAE. Structurally similar to PEA, it is synthesized in the small intestine after eating dietary fats. It does not trigger CB1 or CB2 but instead works through PPAR-alpha to regulate satiety and lipid metabolism.

When OEA levels rise after a meal, it signals to the brain that energy needs are met. This reduces further food intake, supports fat breakdown, and helps prevent obesity. Unlike appetite suppressants that blunt hunger through artificial stimulation, OEA works as a natural metabolic regulator.

The study “Oleoylethanolamide Regulates Feeding and Body Weight Through Activation of the Nuclear Receptor PPAR-Alpha” (2003) demonstrated how OEA reduces meal frequency and fat storage. This positioned OEA as a key bridge between dietary fats and metabolic health.

Because obesity, insulin resistance, and metabolic syndrome are global health concerns, OEA has attracted attention as a therapeutic tool. Beyond weight, it may also support cardiovascular and liver health.

---

Nutrition and Lifestyle: The NAE Connection

Unlike synthetic drugs, NAEs come directly from fatty acid precursors. This means diet and lifestyle choices are major factors in their production.

1. Healthy Fat Intake:
   NAEs are derived from fatty acids such as palmitic, oleic, and linoleic acids. Whole food sources like nuts, seeds, olive oil, avocados, and fish supply the building blocks.
2. Exercise:
   Physical activity influences fatty acid metabolism, which in turn alters NAE levels. Some evidence suggests exercise boosts OEA, helping explain why movement regulates appetite and mood.
3. Stress and Sleep:
   Chronic stress and poor sleep disrupt lipid signaling, potentially lowering beneficial NAE levels. Practices that restore circadian rhythm – consistent sleep, balanced nutrition, and stress reduction – help normalize them.

Through this lens, NAEs represent a direct link between lifestyle and ECS health.

---

Clinical Potential of NAEs

Research on NAEs is expanding. Their ability to regulate inflammation, metabolism, and pain without directly stimulating CB1 or CB2 makes them appealing for medicine.

1. Neuroinflammation and Neuroprotection

• PEA reduces microglial overactivation in conditions like Alzheimer’s and Parkinson’s disease
• OEA may protect neurons by stabilizing lipid metabolism and reducing oxidative stress

2. Pain Management

• PEA shows promise in neuropathic and chronic pain where conventional treatments fail
• Unlike opioids, it does not produce tolerance or dependence.

3. Metabolic Disorders

• OEA reduces overeating and improves fat utilization
• Potential benefits extend to type 2 diabetes, fatty liver disease, and obesity

---

Beyond the ECS: System-Wide Impacts

What makes NAEs remarkable is that their influence extends beyond the ECS. They act on nuclear receptors, ion channels, and orphan GPCRs that regulate:

This suggests NAEs could be targeted in multi-system conditions – where inflammation, metabolism, and neurological function intersect. That includes autoimmune disorders, chronic fatigue syndromes, and even gut-brain axis dysregulation.

---

Integrating NAEs Into a Lifestyle of Balance

The science is clear: NAEs are shaped by how we live. Supporting their production is less about a single supplement and more about daily patterns.

• Eat whole, unprocessed fats rich in omega-3s and monounsaturates
• Move the body regularly to stimulate OEA and metabolic balance
• Prioritize restorative sleep to reset lipid signaling
• Manage stress to prevent immune overactivation and NAE depletion

This lifestyle synergy mirrors the ECS itself – an orchestra of checks and balances fine-tuned by everyday choices.

---

The Bigger Picture: ECS Balance Control

When we zoom out, NAEs are one piece of the larger puzzle of ECS Balance Control. This theory emphasizes that health depends on restoring the ability of the ECS to create, regulate, and recycle its messengers.

• PEA supports anandamide activity and reduces runaway inflammation
  • OEA balances metabolism and appetite signaling
    • Diet provides the raw materials for all these processes

By respecting NAEs, we respect the full depth of The Master Regulator.

---

Conclusion

N-acylethanolamines may not have the spotlight like THC or CBD, but they quietly shape some of the most important processes in human biology. From inflammation to appetite, from nerve protection to metabolic health, these fatty acid messengers represent the elegant interplay between food, lifestyle, and molecular balance.

Two decades of research have shown us that molecules like PEA and OEA are not just biochemical curiosities – they are therapeutic candidates, wellness markers, and reminders of how deeply connected we are to what we eat and how we live.

The endocannabinoid system is not just about cannabis. It is about a network of signals, including NAEs, that help the body remain stable in a chaotic world. Supporting these pathways through a balanced diet, regular movement, and conscious living may be one of the most direct ways to foster resilience, restore balance, and maintain long-term health.

Mike Robinson, Endocannabinoid System Researcher & CEO of Nanobles

References:

1. Palmitoylethanolamide (PEA) activating PPAR-alpha study
   Lo Verme J, Fu J, Astarita G, La Rana G, Russo R, Calignano A, Piomelli D. “The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide.” Molecular Pharmacology. 2005;67(1):15-19. DOI: 10.1124/mol.104.006353 — PubMed link: https://pubmed.ncbi.nlm.nih.gov/15465922/ PubMed
2. Oleoylethanolamide (OEA) role in feeding & body-weight via PPAR-alpha
   Fu J, Gaetani S, Oveisi F, Lo Verme J, Serrano A, Rodríguez de Fonseca F, et al. “Oleoylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.” Nature. 2003;425(6953):90-93. DOI: 10.1038/nature01921 — PubMed link: https://pubmed.ncbi.nlm.nih.gov/12955147/ PubMed